SEC Form 4 · accession 0001127602-19-008813
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James C Foster
Officer — Chairman, President and CEO · Director
Period of report
Feb 26, 2019
Accepted (ET)
Feb 28, 2019 · 9:55 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001100682
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 26, 2019 | S | 200 | $143.41 | D | 282,801 | D | |
| Common Stock | Feb 26, 2019 | S | 200 | $143.42 | D | 282,601 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $143.47 | D | 282,501 | D | |
| Common Stock | Feb 26, 2019 | S | 400 | $143.58 | D | 282,101 | D | |
| Common Stock | Feb 26, 2019 | S | 30 | $143.715 | D | 282,071 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $143.76 | D | 281,971 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $143.845 | D | 281,871 | D | |
| Common Stock | Feb 26, 2019 | S | 300 | $143.85 | D | 281,571 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $144.19 | D | 281,471 | D | |
| Common Stock | Feb 26, 2019 | S | 100 | $144.59 | D | 281,371 | D | |
| Common Stock | Feb 27, 2019 | F | 2,171 | $140.71 | D | 279,200 | D | |
| Common Stock | holding | — | — | — | 18,390 | I | 2017 GRAT | |
| Common Stock | holding | — | — | — | 25,000 | I | 2018 GRAT | |
| Common Stock | holding | — | — | — | 340 | I | By Trust | |
| Common Stock | holding | — | — | — | 10,000 | I | Held By Spouse |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale occurred pursuant to a 10b5-1 Trading Plan.